University of California San Francisco
Give to UCSF
Refugees who fled to Europe a generation ago are significantly more likely to have developed type 2 diabetes if they initially settled in poor neighborhoods, according to a study of 60,000 refugees who came to Sweden between 1987 and 1991.
Exciting advances in medicine and health are being researched in precision medicine projects recently funded by the George and Judy Marcus Program in Precision Medicine Innovation.
New research by UCSF scientists could accelerate – by 10 to 100-fold – the pace of many efforts to profile gene activity, ranging from basic research into how to build new tissues from stem cells to clinical efforts to detect cancer or auto-immune diseases by profiling single cells in a tiny drop of blood.
With one drug to shut down its progression and another to undo its damage, plus a worldwide effort stalking the origins of multiple sclerosis, MS doesn’t stand a chance.
Stem cell biologists at UCSF have demonstrated that IL-1 itself directly transforms the blood system by driving blood stem cells in the bone marrow to switch away from their restorative, rejuvenating role in blood renewal and towards emergency production of immune cells.
Global malaria eradication is possible within a generation, but only with renewed focus, new tools and sufficient financial support, according to a paper published in The Lancet by the Global Health Group’s Malaria Elimination Initiative at UCSF.
Frontotemporal dementia, the second most common cause of dementia in people under 65, may be triggered by a defect in immune cells called microglia that causes them to consume the brain’s synaptic connections, according to new research led by UCSF scientists.
UCSF researchers have discovered that the chances of survival for patients with pancreatic adenocarcinoma (PDAC) — the most common type of pancreatic cancer — may depend in part on how tense their tumors are.
In a study of 10 children published online in the American Journal of Human Genetics on April 14, the researchers linked a constellation of birth defects affecting the brain, eye, ear, heart and kidney to mutations in a single gene, called RERE.
Renowned UCSF immunologist Jeffrey Bluestone, PhD, has been named president and CEO of the Parker Institute for Cancer Immunotherapy, a national initiative launched with a $250 million grant from The Parker Foundation, established by Silicon Valley entrepreneur Sean Parker.
To keep a person's heart healthy, clinicians recommend avoiding risk factors such as smoking or excessive weight gain. But one risk factor, which cannot be changed, is being South Asian.
Nurse interactions with pharmaceutical and device companies are commonplace and beneficial, but they also can lead to conflicts of interest regarding drug treatment and purchasing decisions, according to researchers at UCSF.
This week, the Diabetes Center at UCSF announced that it has embarked on a precision medicine initiative with Yes Health, an all-mobile program to prevent type 2 diabetes.
For the third year in a row, UCSF's four schools — of Dentistry, Medicine, Nursing and Pharmacy — topped the nation in federal biomedical research funding in their fields, according to 2015 figures from the National Institutes of Health.
